Filing Flows › Novo Nordisk A S (NVO) › Gross margin
Novo Nordisk A S (NVO) gross margin by quarter
Novo Nordisk A S' gross margin was 77.0% in Q3 2026 (third quarter 2026), -1.2 pts from Q2 2026. Over the last 6 quarters it ranged from 76.1% (Q3 2025) to 86.0% (Q1 2026).
| Quarter | Gross margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 77.0% | -1.2 pts | +0.9 pts |
| Q2 2026 | 78.2% | -7.7 pts | -5.1 pts |
| Q1 2026 | 86.0% | +5.1 pts | — |
| Q4 2025 | 80.9% | +4.7 pts | — |
| Q3 2025 | 76.1% | -7.2 pts | — |
| Q2 2025 | 83.3% | — | — |
Q3 2026 at a glance
Novo Nordisk A S, Q3 2026: revenue $79.2B (+6% year over year), operating margin 29.1%, net earnings $16.7B, operating cash flow $41.7B. The chart follows the revenue to costs, profit and cash.
Questions
What is Novo Nordisk A S' gross margin?
Novo Nordisk A S' gross margin was 77.0% in Q3 2026 (third quarter 2026), -1.2 pts from Q2 2026.
How has Novo Nordisk A S' gross margin changed?
Over the last 6 quarters it ranged from 76.1% (Q3 2025) to 86.0% (Q1 2026).